Avid Radiopharmaceuticals Company

Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.

Headquarters: Philadelphia, Pennsylvania, United States
Founded Date: 1/1/2005
Estimated Revenue: $10M to $50M
Number Of Exists: 51-100
Industry: Chronic Human Diseases
Funding Status: M&A